Fatal capillary leak syndrome in a child with acute lymphoblastic leukemia treated with moxetumomab pasudotox for pre-transplant minimal residual disease reduction

Affiliations

• ¹ Pediatric Oncology Branch, National Cancer Institute, National Institutes of Health, Bethesda, Maryland.
• ² Pediatric Hematology, Oncology and Stem Cell Transplantation, Ann & Robert H. Lurie Children's Hospital of Chicago, Northwestern University Feinberg School of Medicine, Chicago, Illinois.
• ³ Clinical Pharmacology and Safety Sciences, AstraZeneca, San Francisco, California.
• ⁴ Pediatric Hematology-Oncology, Children's Hospital Los Angeles, Norris Comprehensive Cancer Center, Keck School of Medicine, University of Southern California, Los Angeles, California.
• ⁵ Pediatric Oncology, Children's Hospital Colorado, Denver, Colorado.
• ⁶ Pediatric Oncology, Duke University Medical Center, Durham, North Carolina.
• ⁷ Division of Hematology and Oncology, British Columbia Children's Hospital, Vancouver, British Columbia, Canada.
• ⁸ Pediatric Hematology and Oncology, Boston Children's Hospital, Dana-Farber Cancer Institute, Boston, Massachusetts.
• ⁹ Hematology/Oncology, Hospital for Sick Children, Toronto, Ontario, Canada.
• ¹⁰ Department of Pathology, University of Washington, Seattle, Washington.
• ¹¹ National Marrow Donor Program/Be the Match, Minneapolis, Minnesota.
• ¹² Center for International Blood and Marrow Transplant Research, Minneapolis, Minnesota.